5-MeO-DMT

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind.

Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.

Beyond the toad's kiss: Mapping acute 5-MeO-DMT effects on brain connectivity across sex and dose using awake rat neuroimaging.

Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.

Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study.

Clinical pharmacology.

Serotonergic psychedelics for depression: A comprehensive overview.

Evidence that 5-HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.

Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.

The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.

Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI

Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.

Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.

Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.

Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety

Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.

Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.

Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders.

Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.

Molecular Imaging Study of Harmine/DMT: a Basic Research Approach

Psychedelics for treatment resistant depression: are they game changers?

Safety and Pharmacokinetics of GH002 in Healthy Volunteers

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).

A narrative synthesis of research with 5-MeO-DMT.

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms

Safety of GH001 in Healthy Volunteers

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions